Schedule 13D ownership disclosure

ACELRX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00444T100

Event date: 2018-05-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-172227
Form type
SC 13D/A
Filer
TALPHERA, INC.
CIK
CIK 1427925
Filed
May 24, 2018
Reporting period
May 21, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub